Future Virology. 2013;8(1):1-2. During the global 2002/2003 SARS pandemic, many foundations, pharmaceutical companies and governments provided abundant funds to support the development of anti-SARS ...
Since early 2020, unprecedented efforts have been devoted to design, test and deploy vaccines that can safely elicit robust and durable immunity against SARS-CoV-2. Platform technologies range from ...
The rapid emergence of SARS-CoV-2 spurred an unprecedented global effort to develop vaccines capable of preventing COVID-19 and curbing viral transmission. Early vaccine platforms harnessed ...
Most vaccines are designed to provide immunity against just one pathogen. Vaccines for chicken pox (caused by varicella-zoster virus) were only developed to fight that one disease, for example. But in ...
In the early 2000s, immunologist Bali Pulendran started his lab at Emory University to explore the mechanisms underlying vaccine-mediated immunity. To uncover these processes, he focused on the yellow ...
Much research to elucidate potential antigens, routes of vaccination, and methods for the design of SARS vaccines has been completed. Immunogenicity has been widely demonstrated, but identification of ...
When the SARS coronavirus spread around the world in 2003, it resulted in more than 8,000 cases, nearly 800 deaths, and $50 billion in economic damage. During this time, understandably, there was ...
The story of the emergence, spread, and control of severe acute respiratory syndrome (SARS) is the latest, most vivid episode of a microbial threat in our highly connected world. The SARS epidemic of ...
China is about to start the world’s first clinical trials of a vaccine against SARS. But other scientists fear the Chinese might be moving too fast. Previous research with coronaviruses similar to ...
Read Coronavirus vaccine latest news on The Economic Times. When will coronavirus vaccine be available in India? Coronavirus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results